Protocol considerations for thoracic positron emission tomography-computed tomography.
The rapid technological advances of positron emission tomography-computed tomography (PET-CT) have introduced many new possibilities and questions as to how best to utilize and perform 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET-CT for maximum clinical benefit. The focus of this discussion is the tailoring of PET-CT protocols, emphasizing the incorporation of optimized (diagnostic) CT techniques, for adult thoracic oncologic indications. Many of the protocol strategies described, particularly those involving breath-hold and contrast-enhanced CT, are based on the author's experience in a busy private practice PET-CT center, prior to a recent transition to an academic practice.
Shyn
Paul B
PB
Department of Radiology, Harvard Medical School, Brigham and Women's Hospital, Boston, MA 02115, USA. pshyn@partners.org
D002289:Carcinoma, Non-Small-Cell Lung / Q000175:diagnosis; D003287:Contrast Media; D004938:Esophageal Neoplasms / Q000175:diagnosis; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis; D008223:Lymphoma / Q000175:diagnosis; D049268:Positron-Emission Tomography / Q000379:methods*; D003074:Solitary Pulmonary Nodule / Q000175:diagnosis; D014057:Tomography, X-Ray Computed / Q000379:methods*
D003287:Contrast Media